Evidence
Diabetes Metab Syndr Obes. 2024 Jan 22;17:283-294. doi: 10.2147/DMSO.S397643. eCollection 2024.
ABSTRACT
Non-Alcoholic Fatty Pancreas disease (NAFPD), characterized by fat accumulation in pancreatic tissue, is an emerging clinical entity. However, the clinical associations, the underlying molecular drivers, and the pathophysiological mechanisms of NAFPD have not yet been characterized in detail. The NAFPD spectrum not only includes infiltration and accumulation of fat within and between pancreatic cells but also involves several inflammatory processes, dysregulation of physiological metabolic pathways, and hormonal defects. A deeper understanding of the underlying molecular mechanisms is key to correlate NAFPD with clinical entities including non-alcoholic fatty liver disease, metabolic syndrome, diabetes mellitus, atherosclerosis, as well as pancreatic cancer and pancreatitis. The aim of this review is to examine the pathophysiological mechanisms of NAFPD and to assess the possible causative/predictive risk factors of NAFPD-related clinical syndromes.
PMID:38283640 | PMC:PMC10813232 | DOI:10.2147/DMSO.S397643
Add to Google Keep
Post to X
Share on Linkedin
Estimated reading time: 3 minute(s)
Latest: Psychiatryai.com #RAISR4D
Cool Evidence: Engaging Young People and Students in Real-World Evidence ☀️
Real-Time Evidence Search [Psychiatry]
AI Research [Andisearch.com]
Pathophysiological Mechanisms and Clinical Associations of Non-Alcoholic Fatty Pancreas Disease
🌐 90 Days
VR Related Evidence Matrix
Evidence Blueprint
Pathophysiological Mechanisms and Clinical Associations of Non-Alcoholic Fatty Pancreas Disease
☊ AI-Driven Related Evidence Nodes
(recent articles with at least 5 words in title)
More Evidence
Pathophysiological Mechanisms and Clinical Associations of Non-Alcoholic Fatty Pancreas Disease
🌐 365 Days
VR Related Evidence Matrix
